Aquestive Therapeutics rises after pricing $85M stock offering

1 hour ago 1

Aquestive Therapeutics (NASDAQ:AQST) has priced an underwritten offering of 21.25M shares at $4.00 each, expecting $85M in gross proceeds.
Funds will mainly support the potential launch and commercialization of Anaphylm (epinephrine) Sublingual Film for severe allergic reactions, pending FDA approval, as well as for general corporate

Recommended For You